William J. Dreyer, MD
- Texas Medical Center
Medical Director, Heart Failure, Cardiomyopathy and Cardiac Transplantation
Texas Children's Hospital
|Baylor College of Medicine||fellowship||Pediatric Cardiology||1988|
|University of California San Francisco||residency||Pediatrics||1984|
|Vanderbilt University School of Medicine||internship||Pediatrics||1982|
|University of Florida College of Medicine||medical school||Doctor of Medicine||1981|
My clinical interests include cardiac transplantation and advanced heart failure. My ongoing research includes studies evaluating new heart failure therapies, as well as studies to evaluate new therapies and outcomes in cardiac transplantation. I have a special interest in the management of human leukocyte antigen- (HLA) sensitized patients before and after cardiac transplantation.
|American Academy of Pediatrics||Fellow|
|American College of Cardiology||Fellow|
|American Heart Association||Member|
|International Society for Heart and Lung Transplantation||Member|
|Texas Medical Association||Member|
Moulik M, Breinholt JP, Dreyer WJ, Kearney DL, Price JF, Clunie SK, Moffett BS, Kim JK, Rossano JW, Jefferies JL, Thomas AK, Harbes BA, Bowles KA, Smith EO, Bowles NE, Denfield SW, Towbin JA. Viral endomyocardial infection is an independent predictor and potentially treatable risk factor for graft loss and coronary vasculopathy in pediatric cardiac transplant recipients.Journal of the American College of Cardiology 56:582-592, 2010.